Molecular evaluation of BK polyomavirus nephropathy

R B Mannon1, S C Hoffmann, R L Kampen

  • 1Transplantation Branch, National Institutes of Diabetes, and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA. rozm@mail.nih.gov

Summary

Polyomavirus nephropathy (PVN) in kidney transplants shows higher inflammation and fibrosis gene activity than acute rejection. This suggests PVN drives graft loss through similar, yet more intense, molecular pathways than acute rejection.

Related Concept Videos